Korinde Annemarie Jansen

Title: Korinde Annemarie Jansen: Innovator in Pharmaceutical Development

Introduction

Korinde Annemarie Jansen is a prominent inventor based in Loo, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 5 patents to her name, Jansen is recognized for her expertise and dedication to improving medication delivery systems.

Latest Patents

Among her latest patents, Jansen has developed a formulation for pharmaceutical tablets of crystalline type II aripiprazole. This innovative formulation allows for reduced dissolution profile variability upon storage, enhancing the stability and effectiveness of the medication. Additionally, she has created a low dose controlled release tablet that utilizes a tablet-in-tablet design. This design enables low dose pharmaceuticals to be delivered over a prolonged period, with the drug contained in a controlled release matrix in the outer compression coating layer, while the inner tablet core remains unaffected.

Career Highlights

Jansen's career is marked by her commitment to advancing pharmaceutical technology. She works at Synthon B.V., a company known for its focus on developing complex generics and innovative medicines. Her work has not only contributed to the company's success but has also had a positive impact on patient care.

Collaborations

Throughout her career, Jansen has collaborated with several talented individuals, including Farid Abedin Dorkoosh and Gerrit J B Ettema. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Korinde Annemarie Jansen is a trailblazer in the pharmaceutical industry, with a strong portfolio of patents that reflect her innovative spirit. Her work continues to influence the development of effective drug delivery systems, ultimately benefiting patients worldwide.